Health

JUVMO, known generically as tavapadon, targets a different set of brain receptors than any approved Parkinson's treatment before it, and AbbVie says the trial data backs up the pitch.

Novo just licensed a Chinese biotech's oral GLP-1/GIP hopeful, betting a pill can do what Ozempic's needle already built.

The U.K. drug watchdog called GSK's account of a health agency's involvement "grossly misleading" after the company left out the parts of the record that undercut its story.

A phrase as small as "transform obesity care" was enough to get Eli Lilly formally reprimanded for promoting an unapproved drug to the British press, and its appeal only made the ruling stick harder.

The smart-home-gym maker is repositioning as an AI-powered fitness platform, adding a fourth hardware device and three named AI systems it says will follow users from workout to recovery to daily life.

A Bloomberg report says Apple is prototyping a screenless health band aimed straight at Whoop, Oura, and Garmin, a wearables strategy shift that says more about who Apple's scared of than what it's building.

CagriSema topped tirzepatide on weight loss in a head-to-head phase 3 trial — at the lowest dose tested — handing Novo the competitive line it has been missing.

A handful of layoffs on the audio side of Apple Fitness+ landed Monday, reported inside the service as the opening move of a much larger reckoning.

The supplement brand's first bricks-and-mortar launch in the UK and Ireland puts its core blend into 50 Holland & Barrett stores, scaling to 400 by November 9.

The Swiss running brand names Mbappé the face of a new football category, with LightSpray boots planned for 2027.

Providence Equity bids about EUR 600 million for the French chain, with four finalists left.

"The Weigh In," made with Dear Media and hosted by Samhita Mukhopadhyay, runs eight episodes in season one.

The 36,000-square-foot Philadelphia site opens September 25 with day passes from $29.

A $39-a-month perimenopause supplement arrives with a TV spot from Giant Spoon and a celebrity spokesperson due October 1.

The six-month Health Ambassador pilot is staffed by pharmacists.

The September update also pre-installs Strava on Galaxy Watch9 and Ultra2 with a 60-day trial.

The luxury automaker becomes official national vehicle partner for eight North American races, starting in Boston in October.

Seven Midi Health products are online and five are headed to more than 300 Ulta stores, in what Ulta calls its first tie-up with a dedicated women's health platform.

Starting at $399, the new watch adds a 0 to 10 Readiness Score and more frequent HRV readings. It reached stores September 18.

Q2 revenue fell 4% to about $2.4 billion, comparable sales dropped 9%, and Heidi O'Neill started as CEO on September 8.

An L Catterton-led consortium is buying a majority stake from Infront Sports & Media, with founders Christian Toetzke and Moritz Fuerste regaining majority control.

Sonera makes non-invasive magnetic sensors. No terms were announced, and one report says the deal closed in May.

The smart ring maker filed an S-1 on September 3 for a Nasdaq listing, reporting $1.21 billion in nine-month revenue and 5 million paid members.

Surf expands its HYROX partnership to the U.K., Ireland, and Latin America.